Two sides of 'his­toric' drug pric­ing bill: Phar­ma in­dus­try blasts 'mis­take' while ad­vo­cates plan for 'first ever' gains

Both Con­gres­sion­al De­moc­rats and the phar­ma in­dus­try agree that pend­ing drug pric­ing leg­is­la­tion is “his­toric” — they just di­a­met­ri­cal­ly dis­agree on the mod­i­fi­er.

Trade in­dus­try group PhRMA’s CEO Stephen Ubl called it an “his­toric mis­take” on Wednes­day, joined by Eli Lil­ly CEO David Ricks, At­las Ven­ture part­ner Jean-Fran­cois Formela along with a hema­tol­ogy on­col­o­gy-lead­ing physi­cian and a metasta­t­ic breast can­cer sur­vivor in a press con­fer­ence.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER